The CTIC chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CTIC chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The CTIC stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View CTIC Detailed Price Forecast - CNN Money||View CTIC Detailed Summary - Google Finance|
|View CTIC Detailed Summary - Yahoo! Finance||View CTIC Stock Research & Analysis - Zacks.com|
|View CTIC Trends & Analysis - Trade-Ideas||View CTIC Major Holders - Barrons|
|View CTIC Call Transcripts - NASDAQ||View CTIC Breaking News & Analysis - Seeking Alpha|
|View CTIC Annual Report - CompanySpotlight.com||View CTIC OTC Short Report - OTCShortReport.com|
|View CTIC Fundamentals - TradeKing||View CTIC SEC Filings - Bar Chart|
|View Historical Prices for CTIC - The WSJ||View Performance/Total Return for CTIC - Morningstar|
|View the Analyst Estimates for CTIC - MarketWatch||View the Earnings History for CTIC - CNBC|
|View the CTIC Earnings - StockMarketWatch||View CTIC Buy or Sell Recommendations - MacroAxis|
|View the CTIC Bullish Patterns - American Bulls||View CTIC Short Pain Metrics - ShortPainBot.com|
|View CTIC Stock Mentions - StockTwits||View CTIC Stock Mentions - PennyStockTweets|
|View CTIC Stock Mentions - Twitter||View CTIC Investment Forum News - Investor Hub|
|View CTIC Stock Mentions - Yahoo! Message Board||View CTIC Stock Mentions - Seeking Alpha|
|View Insider Transactions for CTIC - SECform4.com||View Insider Transactions for CTIC - Insider Cow|
|View CTIC Major Holdings Summary - CNBC||View Insider Disclosure for CTIC - OTC Markets|
|View Insider Transactions for CTIC - Yahoo! Finance||View Institutional Holdings for CTIC - NASDAQ|
|View CTIC Stock Insight & Charts - FinViz.com||View CTIC Investment Charts - StockCharts.com|
|View CTIC Stock Overview & Charts - BarChart||View CTIC User Generated Charts - Trading View|
CTI BioPharma to Present at the 7th Annual Leerink Partners Global Healthcare Conference
Posted on Wednesday February 14, 2018
SEATTLE , Feb. 14, 2018 /PRNewswire/ -- CTI BioPharma Corp. (CTI BioPharma) (NASDAQ: CTIC) today announced that management will present at the 7 th Annual Leerink Partners Global Healthcare Conference ...
CTI BioPharma Announces Closing Of Underwritten Public Offering Of Common Stock
Posted on Tuesday February 13, 2018
SEATTLE, Feb. 13, 2018 /PRNewswire/ -- CTI BioPharma Corp. ("CTI BioPharma") (CTIC) today announced the closing of its previously announced underwritten public offering of 20,000,000 shares of its common stock, at a public offering price of $3.00 per share of common stock. In addition, the underwriters exercised in full their option to purchase 3,000,000 additional shares of common stock at the public offering price, less the underwriting discount. The expected proceeds to CTI BioPharma from the offering are approximately $64.2 million, after deducting underwriting discounts and commissions and other estimated offering expenses payable by CTI BioPharma.
CTI BioPharma Prices Underwritten Public Offering of $60 Million of Common Stock
Posted on Friday February 09, 2018
SEATTLE, Feb. 9, 2018 /PRNewswire/ -- CTI BioPharma Corp. (CTI BioPharma) (CTIC) today announced the pricing of an underwritten public offering of 20,000,000 shares of its common stock, at a public offering price of $3.00 per share of common stock. In addition, CTI BioPharma has granted the underwriters a 30-day option to purchase up to an additional 3,000,000 shares of common stock at the public offering price, less the underwriting discount. Proceeds to CTI BioPharma from the offering are expected to be $55.8 million, after deducting underwriting discounts and commissions and other estimated offering expenses payable by CTI BioPharma.
CTI BioPharma Announces Launch of Follow-On Offering
Posted on Monday February 05, 2018
SEATTLE, Feb. 5, 2018 /PRNewswire/ -- CTI BioPharma Corp. (CTI BioPharma) (CTIC) today announced the launch of a proposed underwritten public offering of shares of its common stock. In addition, CTI BioPharma expects to grant the underwriters a 30-day option to purchase additional shares of its common stock. The Company intends to use the net proceeds of the offering to complete the PAC203 clinical trial, complete the review of the pacritinib MAA by the EMA, conduct additional research concerning the possible application of pacritinib in indications outside of myelofibrosis, and complete the PIX306 clinical trial, as well as for general corporate purposes, which may include funding research and development, conducting preclinical and clinical trials, acquiring or in-licensing potential new pipeline candidates, preparing and filing possible new drug applications and general working capital.